| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.14B | 34.37B | 31.89B | 30.33B | 27.30B | 24.48B |
| Gross Profit | 10.18B | 9.49B | 8.48B | 7.54B | 8.09B | 7.14B |
| EBITDA | 2.95B | 2.75B | 2.43B | 1.89B | 2.77B | 2.30B |
| Net Income | 943.00M | 1.01B | 1.28B | 614.00M | 1.81B | 517.00M |
Balance Sheet | ||||||
| Total Assets | 36.57B | 38.30B | 37.05B | 32.02B | 29.01B | 27.71B |
| Cash, Cash Equivalents and Short-Term Investments | 5.07B | 5.51B | 5.64B | 4.26B | 4.00B | 4.11B |
| Total Debt | 4.48B | 5.26B | 6.18B | 2.99B | 968.00M | 3.36B |
| Total Liabilities | 12.24B | 13.29B | 13.93B | 10.78B | 8.46B | 9.54B |
| Stockholders Equity | 21.14B | 21.68B | 20.13B | 18.53B | 17.96B | 15.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.78B | 482.00M | -768.00M | 1.40B | 1.62B |
| Operating Cash Flow | 0.00 | 2.75B | 2.93B | 515.00M | 2.33B | 2.09B |
| Investing Cash Flow | 0.00 | -1.21B | -4.25B | -1.17B | 603.00M | -660.00M |
| Financing Cash Flow | 0.00 | -1.68B | 2.82B | 1.23B | -2.94B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥17.64B | 4.76 | ― | 3.03% | 1.59% | -26.64% | |
79 Outperform | ¥21.47B | 7.90 | ― | 5.21% | 0.91% | 100.31% | |
71 Outperform | ¥20.27B | 4.28 | ― | 3.61% | 8.85% | 110.05% | |
69 Neutral | ¥13.71B | 16.46 | ― | 3.23% | 13.09% | 89.45% | |
66 Neutral | ¥16.64B | 9.21 | ― | 2.78% | 1.30% | -5.03% | |
66 Neutral | ¥23.66B | 5.80 | ― | 4.62% | 7.19% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |